Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0001437749-26-000921 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-08 | 2026-01-06+ | PBYI | NOUGUES MAXIMO F | CFO | S - Sale | $5.86 | -10.9K | 193.3K | -5% | -$64.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | S | D | 4,540 | $5.84 | 199,689 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-07 | S | D | 6,405 | $5.88 | 193,284 | D | — | — |